Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced the launch of a proposed public offering of $175 million of its Class A common stock, subject to market and other conditions. In addition, Evolent Health expects to grant the underwriters a 30-day option to purchase an additional $26.25 million of its Class A common stock in connection with the proposed public offering. All shares of Class A common stock will be offered by Evolent Health.
J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and as representatives of the underwriters for the offering. Wells Fargo Securities, LLC, William Blair & Company, L.L.C. and SunTrust Robinson Humphrey, Inc. are acting as lead managers, and Leerink Partners LLC and Robert W. Baird & Co. Incorporated are acting as co-managers.
Evolent Health intends to transfer the net proceeds from this offering to the subsidiary through which its operations are conducted, Evolent Health LLC. Evolent Health LLC expects to use such net proceeds for working capital and other general corporate purposes, including to expand its business through acquisitions and investments.
About Evolent Health
Evolent Health partners with leading provider organizations to achieve superior clinical and financial results in value-based care. With a provider heritage and over 20 years of health plan administration experience, Evolent operates in more than 30 U.S. health care markets, actively managing care across Medicare, Medicaid, commercial and self-funded adult and pediatric populations. With the experience to drive change, Evolent confidently stands by a commitment to achieve results. For more information, visit evolenthealth.com.